Skip to content
April 3, 2025
Latest
Lumai secures over $10M investment for optical processing tech
Builder.ai undergoes “significant restructuring” as it restates past accounts
Fintech Next Generation acquires Lugh in order to launch digital payments
Wireless Logic expands to Latin America with Arqia acquisition
How a Slovak startup Is tackling enterprise IT’s biggest headache
EU Information Service
Good news from around Europe
Home
Startups
EU Funding
About
Promote your project
Home
Startups
EU Funding
About
Promote your project
Search for:
Home
Tech
Research Headlines – BLUEPRINT for research success in blood disease therapy
Research Headlines – BLUEPRINT for research success in blood disease therapy
On
August 24, 2017
By
admin
The EU-funded BLUEPRINT project has generated extensive epigenome data on healthy and diseased blood cells, developed new analysis methods and uncovered new information on how the innate immune system works.
Powered by
WPeMatico
Share this:
Click to share on Facebook (Opens in new window)
Click to share on Twitter (Opens in new window)
Click to share on LinkedIn (Opens in new window)
Click to email a link to a friend (Opens in new window)
Click to print (Opens in new window)
Related
Post navigation
PREVIOUS POST
Previous post:
Success Stories – More sustainable, healthier wine? We’ll drink to that!
NEXT POST
Next post:
Eight European Regios are working together for a #circular #economy in the #interreg project @CircEconomy. Together we find #opportunities.